At present, NSCLC targets have been found, including epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), receptor tyrosine kinase ROS proto-oncogene 1 (ROS1) and Kirsten rat sarcoma virus oncogene (KRAS). Here, ROS1 is linked to non-small cell lung carcinoma.